Do analysts rate SYRA or YI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Syra Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 111 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, SYRA or YI?

Syra Health has higher earnings, but lower revenue than 111. 111 is trading at a lower price-to-earnings ratio than Syra Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Syra Health $7.98M 1.56 -$2.94M $0.01 90.00 111 $1.80B 0.02 -$9.65M -$1.40 N/A

Is SYRA or YI more profitable?

111 has a net margin of -0.76% compared to Syra Health's net margin of -54.90%. 111's return on equity of 0.00% beat Syra Health's return on equity. Company Net Margins Return on Equity Return on Assets Syra Health -54.90% -131.94% -99.19% 111 -0.76% N/A -3.80%

Do analysts prefer SYRA or CCM?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Syra Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, SYRA or CCM?

Syra Health has higher earnings, but lower revenue than Concord Medical Services. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Syra Health $7.98M 1.56 -$2.94M $0.01 90.00 Concord Medical Services $65.85M 0.31 -$13.27M N/A N/A

Does the media prefer SYRA or CCM?

In the previous week, Concord Medical Services had 1 more articles in the media than Syra Health. MarketBeat recorded 3 mentions for Concord Medical Services and 2 mentions for Syra Health. Syra Health's average media sentiment score of 0.00 beat Concord Medical Services' score of -0.25 indicating that Syra Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Syra Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Concord Medical Services 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer COSM or SYRA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Syra Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Does the media favor COSM or SYRA?

In the previous week, Cosmos Health and Cosmos Health both had 2 articles in the media. Cosmos Health's average media sentiment score of 0.94 beat Syra Health's score of 0.00 indicating that Cosmos Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cosmos Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Syra Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend BMGL or SYRA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Basel Medical Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Syra Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better earnings & valuation, BMGL or SYRA?

Syra Health has lower revenue, but higher earnings than Basel Medical Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Basel Medical Group $8.90M 0.94 -$9.50M N/A N/A Syra Health $7.98M 1.56 -$2.94M $0.01 90.00

Does the media refer more to BMGL or SYRA?

In the previous week, Basel Medical Group had 2 more articles in the media than Syra Health. MarketBeat recorded 4 mentions for Basel Medical Group and 2 mentions for Syra Health. Basel Medical Group's average media sentiment score of 0.89 beat Syra Health's score of 0.00 indicating that Basel Medical Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Basel Medical Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Syra Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend WGRX or SYRA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Syra Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Syra Health (SYRA) Competitors

$0.90 0.00 (0.00%)

As of 08/14/2026 03:42 PM Eastern

Compare

SYRA vs. YI, CCM, COSM, BMGL, and WGRX

Should you buy Syra Health stock or one of its competitors? Syra Health's main competitors and comparable companies include 111 (YI), Concord Medical Services (CCM), Cosmos Health (COSM), Basel Medical Group (BMGL), and Wellgistics Health (WGRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Syra Health compare to 111?

Syra Health (NASDAQ:SYRA) and 111 (NASDAQ:YI) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation, dividends and media sentiment.

In the previous week, Syra Health had 1 more articles in the media than 111. MarketBeat recorded 2 mentions for Syra Health and 1 mentions for 111. 111's average media sentiment score of 1.87 beat Syra Health's score of 0.00 indicating that 111 is being referred to more favorably in the news media.

Company	Overall Sentiment
Syra Health	Neutral
111	Very Positive

4.8% of Syra Health shares are owned by institutional investors. Comparatively, 21.3% of 111 shares are owned by institutional investors. 36.5% of Syra Health shares are owned by company insiders. Comparatively, 43.9% of 111 shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Syra Health has a beta of 2.86, indicating that its share price is 186% more volatile than the broader market. Comparatively, 111 has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market.

111 has a net margin of -0.76% compared to Syra Health's net margin of -54.90%. 111's return on equity of 0.00% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Syra Health	-54.90%	-131.94%	-99.19%
111	-0.76%	N/A	-3.80%

Syra Health has higher earnings, but lower revenue than 111. 111 is trading at a lower price-to-earnings ratio than Syra Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Syra Health	$7.98M	1.56	-$2.94M	$0.01	90.00
111	$1.80B	0.02	-$9.65M	-$1.40	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
111	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

111 beats Syra Health on 8 of the 14 factors compared between the two stocks.

How does Syra Health compare to Concord Medical Services?

Syra Health (NASDAQ:SYRA) and Concord Medical Services (NYSE:CCM) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.

Concord Medical Services has a net margin of 0.00% compared to Syra Health's net margin of -54.90%. Concord Medical Services' return on equity of 0.00% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Syra Health	-54.90%	-131.94%	-99.19%
Concord Medical Services	N/A	N/A	N/A

4.8% of Syra Health shares are held by institutional investors. 36.5% of Syra Health shares are held by company insiders. Comparatively, 46.5% of Concord Medical Services shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Syra Health has a beta of 2.86, suggesting that its stock price is 186% more volatile than the broader market. Comparatively, Concord Medical Services has a beta of -0.97, suggesting that its stock price is 197% less volatile than the broader market.

In the previous week, Concord Medical Services had 1 more articles in the media than Syra Health. MarketBeat recorded 3 mentions for Concord Medical Services and 2 mentions for Syra Health. Syra Health's average media sentiment score of 0.00 beat Concord Medical Services' score of -0.25 indicating that Syra Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Syra Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Concord Medical Services	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Syra Health has higher earnings, but lower revenue than Concord Medical Services.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Syra Health	$7.98M	1.56	-$2.94M	$0.01	90.00
Concord Medical Services	$65.85M	0.31	-$13.27M	N/A	N/A

Summary

Concord Medical Services beats Syra Health on 7 of the 12 factors compared between the two stocks.

How does Syra Health compare to Cosmos Health?

Cosmos Health (NASDAQ:COSM) and Syra Health (NASDAQ:SYRA) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.

Cosmos Health has a net margin of -30.41% compared to Syra Health's net margin of -54.90%. Cosmos Health's return on equity of -52.85% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cosmos Health	-30.41%	-52.85%	-17.87%
Syra Health	-54.90%	-131.94%	-99.19%

Cosmos Health has a beta of 4.8, suggesting that its stock price is 380% more volatile than the broader market. Comparatively, Syra Health has a beta of 2.86, suggesting that its stock price is 186% more volatile than the broader market.

In the previous week, Cosmos Health and Cosmos Health both had 2 articles in the media. Cosmos Health's average media sentiment score of 0.94 beat Syra Health's score of 0.00 indicating that Cosmos Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cosmos Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Syra Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

12.6% of Cosmos Health shares are held by institutional investors. Comparatively, 4.8% of Syra Health shares are held by institutional investors. 26.2% of Cosmos Health shares are held by insiders. Comparatively, 36.5% of Syra Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Syra Health has lower revenue, but higher earnings than Cosmos Health. Cosmos Health is trading at a lower price-to-earnings ratio than Syra Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cosmos Health	$65.27M	0.20	-$19.15M	-$0.64	N/A
Syra Health	$7.98M	1.56	-$2.94M	$0.01	90.00

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Cosmos Health beats Syra Health on 9 of the 13 factors compared between the two stocks.

How does Syra Health compare to Basel Medical Group?

Basel Medical Group (NASDAQ:BMGL) and Syra Health (NASDAQ:SYRA) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation.

Syra Health has lower revenue, but higher earnings than Basel Medical Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Basel Medical Group	$8.90M	0.94	-$9.50M	N/A	N/A
Syra Health	$7.98M	1.56	-$2.94M	$0.01	90.00

Basel Medical Group has a beta of 0.24, suggesting that its stock price is 76% less volatile than the broader market. Comparatively, Syra Health has a beta of 2.86, suggesting that its stock price is 186% more volatile than the broader market.

Basel Medical Group has a net margin of 0.00% compared to Syra Health's net margin of -54.90%. Basel Medical Group's return on equity of 0.00% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Basel Medical Group	N/A	N/A	N/A
Syra Health	-54.90%	-131.94%	-99.19%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Basel Medical Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Basel Medical Group had 2 more articles in the media than Syra Health. MarketBeat recorded 4 mentions for Basel Medical Group and 2 mentions for Syra Health. Basel Medical Group's average media sentiment score of 0.89 beat Syra Health's score of 0.00 indicating that Basel Medical Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Basel Medical Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Syra Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

4.8% of Syra Health shares are owned by institutional investors. 36.5% of Syra Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Basel Medical Group beats Syra Health on 7 of the 12 factors compared between the two stocks.

How does Syra Health compare to Wellgistics Health?

Wellgistics Health (NASDAQ:WGRX) and Syra Health (NASDAQ:SYRA) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

4.8% of Syra Health shares are owned by institutional investors. 27.0% of Wellgistics Health shares are owned by company insiders. Comparatively, 36.5% of Syra Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Wellgistics Health has a beta of -1.47, indicating that its stock price is 247% less volatile than the broader market. Comparatively, Syra Health has a beta of 2.86, indicating that its stock price is 186% more volatile than the broader market.

Syra Health has a net margin of -54.90% compared to Wellgistics Health's net margin of -545.69%. Wellgistics Health's return on equity of 0.00% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Wellgistics Health	-545.69%	N/A	-145.69%
Syra Health	-54.90%	-131.94%	-99.19%

In the previous week, Syra Health had 2 more articles in the media than Wellgistics Health. MarketBeat recorded 2 mentions for Syra Health and 0 mentions for Wellgistics Health. Wellgistics Health's average media sentiment score of 0.00 equaled Syra Health'saverage media sentiment score.

Company	Overall Sentiment
Wellgistics Health	Neutral
Syra Health	Neutral

Syra Health has lower revenue, but higher earnings than Wellgistics Health. Wellgistics Health is trading at a lower price-to-earnings ratio than Syra Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wellgistics Health	$23.34M	0.37	-$101.28M	-$44.50	N/A
Syra Health	$7.98M	1.56	-$2.94M	$0.01	90.00

Summary

Syra Health beats Wellgistics Health on 9 of the 13 factors compared between the two stocks.

Get Syra Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SYRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SYRA vs. The Competition

Export

Metric	Syra Health	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$12.46M	$9.88B	$7.00B	$13.04B
Dividend Yield	N/A	2.54%	2.56%	10.42%
P/E Ratio	-1.38	35.17	271.55	25.35
Price / Sales	1.56	4.83	603.37	100.47
Price / Cash	N/A	24.81	28.87	38.43
Price / Book	1.45	5.28	11.17	6.52
Net Income	-$2.94M	$311.06M	$3.45B	$346.81M
7 Day Performance	35.34%	0.03%	0.98%	1.27%
1 Month Performance	11.97%	-0.20%	2.30%	2.57%
1 Year Performance	N/A	19.48%	62.38%	20.83%

Syra Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SYRA Syra Health	N/A	$0.90 flat	N/A	+1,043.6%	$12.46M	$7.98M	N/A	78
YI 111	1.2332 of 5 stars	$3.79 +2.4%	N/A	-45.6%	$32.51M	$1.80B	N/A	1,063	Positive News Upcoming Earnings
CCM Concord Medical Services	0.3548 of 5 stars	$4.91 +0.9%	N/A	-10.6%	$21.10M	$65.85M	N/A	970	Analyst Upgrade Short Interest Increase Gap Down
COSM Cosmos Health	2.5453 of 5 stars	$0.22 +2.9%	N/A	-75.7%	$12.90M	$65.27M	N/A	100	News Coverage Gap Down
BMGL Basel Medical Group	0.9491 of 5 stars	$5.66 +1.1%	N/A	-77.2%	$8.76M	$8.90M	N/A	36	Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SYRA) was last updated on 8/17/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Syra Health (SYRA) Competitors

SYRA vs. YI, CCM, COSM, BMGL, and WGRX

How does Syra Health compare to 111?

Summary

How does Syra Health compare to Concord Medical Services?

Summary

How does Syra Health compare to Cosmos Health?

Summary

How does Syra Health compare to Basel Medical Group?

Summary

How does Syra Health compare to Wellgistics Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SYRA vs. The Competition

Syra Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Syra Health (SYRA) Competitors

SYRA vs. YI, CCM, COSM, BMGL, and WGRX

How does Syra Health compare to 111?

Does the media prefer SYRA or YI?

Do insiders and institutionals believe in SYRA or YI?

Which has more risk & volatility, SYRA or YI?

Is SYRA or YI more profitable?

Which has preferable earnings & valuation, SYRA or YI?

Do analysts rate SYRA or YI?

Summary

How does Syra Health compare to Concord Medical Services?

Is SYRA or CCM more profitable?

Do insiders & institutionals hold more shares of SYRA or CCM?

Which has more volatility & risk, SYRA or CCM?

Does the media prefer SYRA or CCM?

Do analysts prefer SYRA or CCM?

Which has stronger valuation & earnings, SYRA or CCM?

Summary

How does Syra Health compare to Cosmos Health?

Is COSM or SYRA more profitable?

Which has more volatility & risk, COSM or SYRA?

Does the media favor COSM or SYRA?

Do institutionals and insiders hold more shares of COSM or SYRA?

Which has preferable valuation & earnings, COSM or SYRA?

Do analysts prefer COSM or SYRA?

Summary

How does Syra Health compare to Basel Medical Group?

Which has better earnings & valuation, BMGL or SYRA?

Which has more risk & volatility, BMGL or SYRA?

Is BMGL or SYRA more profitable?

Do analysts recommend BMGL or SYRA?

Does the media refer more to BMGL or SYRA?

Do insiders and institutionals hold more shares of BMGL or SYRA?

Summary

How does Syra Health compare to Wellgistics Health?

Do insiders & institutionals have more ownership in WGRX or SYRA?

Do analysts recommend WGRX or SYRA?

Which has more risk and volatility, WGRX or SYRA?

Is WGRX or SYRA more profitable?

Does the media prefer WGRX or SYRA?

Which has stronger valuation & earnings, WGRX or SYRA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SYRA vs. The Competition

Syra Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools